Evidence map›Paper›PMID 25473962›Full record

ArticlePLoS pathogens2014

Specific dysregulation of IFNγ production by natural killer cells confers susceptibility to viral infection.

Nassima Fodil, David Langlais, Peter Moussa, Gregory Allan Boivin, Tania Di Pietrantonio, Irena Radovanovic, Anne Dumaine, Mathieu Blanchette, Erwin Schurr, Philippe Gros and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Nassima FodilDepartment of Human Genetics and Department of Microbiology and Immunology, McGill University, Life Sciences Complex, Montreal, Quebec, Canada.
David LanglaisBiochemistry Department, McGill University, Montréal, Québec, Canada.
Peter MoussaDepartment of Human Genetics and Department of Microbiology and Immunology, McGill University, Life Sciences Complex, Montreal, Quebec, Canada.
Gregory Allan BoivinDepartment of Human Genetics and Department of Microbiology and Immunology, McGill University, Life Sciences Complex, Montreal, Quebec, Canada.
Tania Di PietrantonioResearch Institute of the McGill University Health Centre, McGill Centre for the Study of Host Resistance, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Irena RadovanovicBiochemistry Department, McGill University, Montréal, Québec, Canada.
Anne DumaineDepartment of Human Genetics and Department of Microbiology and Immunology, McGill University, Life Sciences Complex, Montreal, Quebec, Canada.
Mathieu BlanchetteMcGill Centre for Bioinformatics and School of Computer Science, McGill University, Montréal, Québec, Canada.
Erwin SchurrResearch Institute of the McGill University Health Centre, McGill Centre for the Study of Host Resistance, Department of Medicine, McGill University, Montreal, Quebec, Canada.
Philippe GrosBiochemistry Department, McGill University, Montréal, Québec, Canada.
Silvia Marina VidalDepartment of Human Genetics and Department of Microbiology and Immunology, McGill University, Life Sciences Complex, Montreal, Quebec, Canada.
McGill University · CAMcGill University Health Centre · CA

Funding

NRAMP1 IN MACROPHAGE DEFENCES AGAINST INFECTIONSR01AI035237 · NIAID · MCGILL UNIVERSITY · PI GROS, PHILIPPE · 1993 to 2015
$2.3M
Canadian Institutes of Health Research MOP-89821NIAID NIH HHS R01 AI035237
6 · The paper itself

Abstract

Natural Killer (NK) cells contribute to the control of viral infection by directly killing target cells and mediating cytokine release. In C57BL/6 mice, the Ly49H activating NK cell receptor plays a key role in early resistance to mouse cytomegalovirus (MCMV) infection through specific recognition of the MCMV-encoded MHC class I-like molecule m157 expressed on infected cells. Here we show that transgenic expression of Ly49H failed to provide protection against MCMV infection in the naturally susceptible A/J mouse strain. Characterization of Ly49H(+) NK cells from Ly49h-A transgenic animals showed that they were able to mount a robust cytotoxic response and proliferate to high numbers during the course of infection. However, compared to NK cells from C57BL/6 mice, we observed an intrinsic defect in their ability to produce IFNγ when challenged by either m157-expressing target cells, exogenous cytokines or chemical stimulants. This effect was limited to NK cells as T cells from C57BL/6 and Ly49h-A mice produced comparable cytokine levels. Using a panel of recombinant congenic strains derived from A/J and C57BL/6 progenitors, we mapped the genetic basis of defective IFNγ production to a single 6.6 Mb genetic interval overlapping the Ifng gene on chromosome 10. Inspection of the genetic interval failed to reveal molecular differences between A/J and several mouse strains showing normal IFNγ production. The chromosome 10 locus is independent of MAPK signalling or decreased mRNA stability and linked to MCMV susceptibility. This study highlights the existence of a previously uncovered NK cell-specific cis-regulatory mechanism of Ifnγ transcript expression potentially relevant to NK cell function in health and disease.

Indexed as

CytomegalovirusGenetic LociGenetic Predisposition to DiseaseAnimalsChromosomes, MammalianCytomegalovirus InfectionsGene Expression Regulation, ViralInterferon-gammaMiceMice, KnockoutNK Cell Lectin-Like Receptor Subfamily ARNA StabilityViral ProteinsInterferon-gammaKlra8 protein, mouseNK Cell Lectin-Like Receptor Subfamily AViral Proteins

Identifiers

PMID25473962
PMCPMC4256466
OpenAlexW1996598263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.